MTOR and neoplasm: Inactivating loss-of-function mutations of the PTEN tumour suppressor gene trigger the over-activation of the mammalian target of rapamycin (mTOR) pathway, which leads to increased cell proliferation, angiogenesis and reduced apoptosis [2].